|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/352 | (2006.01) |
| A61K 31/343 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/352 | (2013.01) | ||
| A61K 31/365 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/704 | (2013.01) | ||
| A61K 31/365 | (2006.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61K 31/475 | (2006.01) | ||
| A61K 31/475 | (2013.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 33/24 | (2013.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 33/24 | (2019.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/343 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Number of the document | 3773548 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19804326.7 |
| Date of filing the European patent application | 2019-05-15 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/032435 |
| Date | 2019-05-15 |
| (87) | Number | WO 2019/222361 |
| Date | 2019-11-21 |
| (30) | Number | Date | Country code |
| 201862672373 P | 2018-05-16 | US |
| (72) |
SINGER, Jamie , US
WACHTER, Eric A. , US
SWIFT, Lucy , CA
ZHANG, Chunfen , CA
TRIPPETT, Tanya , US
NARENDRAN, Aru , CA
THAKUR, Satbir , CA
JAIN, Mohit , CA
|
| (73) |
Provectus Pharmatech, Inc. ,
10025 Investment Drive, Suite 250, Knoxville, Tennessee 37932,
US
The Governors of the University of Calgary , 2500 University Drive NW, Calgary, Alberta T2N 1N4, CA |
| (54) | IN VITRO AND XENOGRAFT ANTI-TUMOR ACTIVITY OF A HALOGENATED-XANTHENE AGAINST REFRACTORY PEDIATRIC SOLID TUMORS |
| IN VITRO AND XENOGRAFT ANTI-TUMOR ACTIVITY OF A HALOGENATED-XANTHENE AGAINST REFRACTORY PEDIATRIC SOLID TUMORS |